Head & Neck Cancers Articles

No Benefit With Postoperative Chemoradiotherapy Versus RT Alone in HNSCC
The addition of weekly carboplatin following surgery and radiation therapy did not improve freedom from locoregional relapse in patients with high-risk cutaneous head and neck squamous cell carcinoma.
FDA Halts Combo Trial of Axalimogene Filolisbac Plus Durvalumab
The FDA has put a clinical hold on a phase I/II study of axalimogene filolisbac plus durvalumab (Imfinzi) for the treatment of patients with cervical cancer or head and neck cancer.
Larotrectinib Update Shows Durable Responses in TRK-positive Cancers
Larotrectinib (LOXO-101) induced durable responses in patients with TRK fusion–positive solid tumors, according to updated results for the novel pan-TRK inhibitor. 
Moving Forward in Head and Neck Squamous Cell Cancer
Development of effective therapies for metastatic head and neck cancer has been challenging, and progress has been slow.
Nearly 7 in 10 patients with locally advanced or metastatic BRAF V600E–mutated anaplastic thyroid cancer responded to treatment with the combination of the BRAF inhibitor dabrafenib and the MEK inhibitor trametinib. 
Evolving Role of Surgery in Multidisciplinary Care for Head and Neck Cancer
Joseph A. Califano, MD, discusses how surgery factors into modern multidisciplinary care for patients with head and neck cancer.
Thyroid Cancer Landscape Advancing to Include Novel Surgical Techniques
Michael Bouvet, MD, highlights the evolving surgical options in the thyroid cancer field
Multidisciplinary Care Critical in Head and Neck Cancer
Assuntina G. Sacco, MD, discusses the importance of multidisciplinary care for patients with head and neck cancer. 
Study Finds Significant Survival Disparities in HPV-related Cancer
Younger patients, women, and white patients with HPV-related cancers had superior survival at 5 years, indicating that increased HPV vaccination and better access to cancer screening and treatment are likely needed to reduce survival disparities
Number of Sexual Partners, Smoking Identified as Risk Factors for Oropharyngeal Cancer
While the incidence of HPV-related oropharyngeal cancer is increasing, the risk for developing the disease remains low for most people.
Publication Bottom Border
Border Publication